HIV and cancer in Africa: Mutual collaboration between HIV and cancer programs may provide timely research and public health data

Infectious Agents and Cancer

Volumn 6, Issue 1, 2011, Pages

  Mbulaiteye, Sam M ^a   Bhatia, Kishor ^a   Adebamowo, Clement ^b   Sasco, Annie J ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; ANUS CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; DISEASE ASSOCIATION; EPIDEMIC; EPIDEMIOLOGICAL DATA; HEALTH PROGRAM; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LUNG CANCER; MORTALITY; NEOPLASM; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QUANTITATIVE ANALYSIS; REVIEW; UTERINE CERVIX CANCER;

EID: 80054058920     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-6-16     Document Type: Review

References (132)

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, Int J Cancer
2. Cancer and globalization. Sasco AJ, Biomed Pharmacother 2008 62 2 110 121 10.1016/j.biopha.2007.10.015 18180137 (Pubitemid 351217093)
3. The challenge of cancer control in Africa. Lingwood RJ, Boyle P, Milburn A, Ngoma T, Arbuthnott J, McCaffrey R, Kerr SH, Kerr DJ, Nat Rev Cancer 2008 8 5 398 403 10.1038/nrc2372 18385682 (Pubitemid 351589700)
4. A million africans a year dying from cancer by 2030: What can cancer research and control offer to the continent? Sylla BS, Wild CP, Int J Cancer 2011
5. Disseminated Kaposi's sarcoma syndrome in young homosexual men. Friedman-Kien AE, J Am Acad Dermatol 1981 5 4 468 471 10.1016/S0190-9622(81) 80010-2 7287964 (Pubitemid 12247094)
6. Kaposi's sarcoma in homosexual men-a report of eight cases. Hymes KB, Cheung T, Greene JB, Prose NS, Marcus A, Ballard H, William DC, Laubenstein LJ, Lancet 1981 2 8247 598 600 6116083 (Pubitemid 11051872)
7. Outbreak of Burkitt's-like lymphoma in homosexual men. Ziegler JL, Drew WL, Miner RC, Mintz L, Rosenbaum E, Gershow J, Lennette ET, Greenspan J, Shillitoe E, Beckstead J, et al. Lancet 1982 2 8299 631 633 6125777 (Pubitemid 12056646)
8. Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. Ziegler JL, Beckstead JA, Volberding PA, Abrams DI, Levine AM, Lukes RJ, Gill PS, Burkes RL, Meyer PR, Metroka CE, et al. N Engl J Med 1984 311 9 565 570 10.1056/NEJM198408303110904 6611504 (Pubitemid 15189207)
9. Kaposi's sarcoma in Uganda: a clinico-pathological study. Taylor JF, Templeton AC, Vogel CL, Ziegler JL, Kyalwazi SK, Int J Cancer 1971 8 1 122 135 10.1002/ijc.2910080116 5118203
10. Distribution of tumours in Uganda. Templeton AC, Hutt MS, Recent Results Cancer Res 1973 41 1 22 4803974
11. Sex habits, recent disease, and drug use in two groups of Danish male homosexuals. Ebbesen P, Melbye M, Biggar RJ, Arch Sex Behav 1984 13 4 291 300 10.1007/BF01541902 6548371 (Pubitemid 14061718)
12. African Kaposi's sarcoma and AIDS. Downing RG, Eglin RP, Bayley AC, Lancet 1984 1 8375 478 480 6142209 (Pubitemid 14193140)
13. Occurrence, clinical behaviour and management of Kaposi's sarcoma in Zambia. Bayley AC, Cancer Surv 1991 10 53 71 1821324
14. Kaposi's sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection. Ziegler JL, Katongole-Mbidde E, Int J Cancer 1996 65 2 200 203 10.1002/(SICI)1097-0215(19960117)65:2<200::AID-IJC12>3.0. CO;2-H 8567117 (Pubitemid 26048915)
15. Spectrum of AIDS-associated malignant disorders. Goedert JJ, Cote TR, Virgo P, Scoppa SM, Kingma DW, Gail MH, Jaffe ES, Biggar RJ, Lancet 1998 351 9119 1833 1839 10.1016/S0140-6736(97)09028-4 9652666 (Pubitemid 28279706)
16. Cancer: the effects of HIV and antiretroviral therapy, and implications for early antiretroviral therapy initiation. Grulich AE, Curr Opin HIV AIDS 2009 4 3 183 187 10.1097/COH.0b013e328329c5b2 19532048
17. Changes in cancer mortality among HIV-infected patients: the Mortalité 2005 Survey. Bonnet F, Burty C, Lewden C, Costagliola D, May T, Bouteloup V, Rosenthal E, Jougla E, Cacoub P, Salmon D, et al. Clin Infect Dis 2009 48 5 633 639 10.1086/596766 19202627
18. Cancer as a cause of death among people with AIDS in the United States. Simard EP, Engels EA, Clin Infect Dis 51 8 957 962
19. UNAIDS Report on the Global AIDS Epidemic 2010, Geneva, Switzerland. Joint United Nations Programme on HIV/AIDS (UNAIDS), http://www.unaids.org/ globalreport/global-report.htm accessed 10th October 2011
20. Epidemiology of AIDS-related malignancies: An international perspective. Mbulaiteye SM, Parkin DM, Rabkin CS, Hematol Oncol Clin North Am 2003 17 3 673 696 v 10.1016/S0889-8588(03)00048-0 12852650 (Pubitemid 36807592)
21. The challenge of AIDS-related malignancies in sub-Saharan Africa. Sasco AJ, Jaquet A, Boidin E, Ekouevi DK, Thouillot F, Lemabec T, Forstin MA, Renaudier P, N'Dom P, Malvy D, et al. PLoS ONE 5 1 8621
22. The increasing burden of HIV-associated malignancies in resource-limited regions. Casper C, Annu Rev Med 62 157 170
23. The global health burden of infection-associated cancers in the year 2002. Parkin DM, Int J Cancer 2006 118 12 3030 3044 10.1002/ijc.21731 16404738
24. Part II: Cancer in Indigenous Africans-causes and control. Sitas F, Parkin DM, Chirenje M, Stein L, Abratt R, Wabinga H, Lancet Oncol 2008 9 8 786 795 10.1016/S1470-2045(08)70198-0 18672214 (Pubitemid 352038317)
25. Epidemiology of HIV/AIDS-United States, 1981-2005. MMWR Morb Mortal Wkly Rep 2006 55 21 589 592 16741494
26. AIDS-related cancer and severity of immunosuppression in persons with AIDS. Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA, J Natl Cancer Inst 2007 99 12 962 972 10.1093/jnci/djm010 17565153 (Pubitemid 47073502)
27. Immune deficiency and risk for malignancy among persons with AIDS. Mbulaiteye SM, Biggar RJ, Goedert JJ, Engels EA, J Acquir Immune Defic Syndr 2003 32 5 527 533 10.1097/00126334-200304150-00010 12679705 (Pubitemid 36423125)
28. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ, J Natl Cancer Inst 2002 94 16 1204 1210 12189223 (Pubitemid 34993870)
29. Trends in cancer risk among people with AIDS in the United States 1980-2002. Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, Biggar RJ, AIDS 2006 20 12 1645 1654 10.1097/01.aids.0000238411.75324.59 16868446 (Pubitemid 44162407)
30. Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007. Shiels MS, Pfeiffer RM, Hall HI, Li J, Goedert JJ, Morton LM, Hartge P, Engels EA, JAMA 305 14 1450 1459
31. Human immunodeficiency virus (HIV) infection codes. Official authorized addendum. ICD-9-CM (Revision No. 1). Effective January 1, 1988. MMWR Morb Mortal Wkly Rep 1987 36 Suppl 7 1S 20S 2826984
32. Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group. Cote TR, Biggar RJ, Rosenberg PS, Devesa SS, Percy C, Yellin FJ, Lemp G, Hardy C, Geodert JJ, Blattner WA, Int J Cancer 1997 73 5 645 650 10.1002/(SICI)1097-0215(19971127)73:5<645:: AID-IJC6>3.0.CO;2-X 9398040 (Pubitemid 127483058)
33. Acquired immune deficiency syndrome in the United States: the first 1,000 cases. Jaffe HW, Bregman DJ, Selik RM, J Infect Dis 1983 148 2 339 345 10.1093/infdis/148.2.339 6604115 (Pubitemid 13002478)
34. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Cavert W, Notermans DW, Staskus K, Wietgrefe SW, Zupancic M, Gebhard K, Henry K, Zhang ZQ, Mills R, McDade H, et al. Science 1997 276 5314 960 964 10.1126/science.276.5314.960 9139661 (Pubitemid 27209096)
35. Evaluation of guidelines for initiation of highly active antiretroviral therapy in a longitudinal cohort of HIV-infected individuals. Ioannidis JP, O'Brien TR, Goedert JJ, AIDS 1998 12 18 2417 2423 10.1097/00002030-199818000- 00010 9875579 (Pubitemid 28558599)
36. The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA Study. Mocroft A, Kirk O, Clumeck N, Gargalianos-Kakolyris P, Trocha H, Chentsova N, Antunes F, Stellbrink HJ, Phillips AN, Lundgren JD, Cancer 2004 100 12 2644 2654 10.1002/cncr.20309 15197808 (Pubitemid 38715771)
37. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 2000 92 22 1823 1830 10.1093/jnci/92.22.1823 11078759
38. Cancer Burden in the HIV-Infected Population in the United States. Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, Bhatia K, Uldrick TS, Yarchoan R, Goedert JJ, et al. J Natl Cancer Inst 103 9 753 762
39. Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States. Simard EP, Pfeiffer RM, Engels EA, Cancer 117 5 1089 1096
40. Elevated risk of lung cancer among people with AIDS. Chaturvedi AK, Pfeiffer RM, Chang L, Goedert JJ, Biggar RJ, Engels EA, AIDS 2007 21 2 207 213 10.1097/QAD.0b013e3280118fca 17197812 (Pubitemid 46036929)
41. Risk of human papillomavirus-associated cancers among persons with AIDS. Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA, J Natl Cancer Inst 2009 101 16 1120 1130 10.1093/jnci/djp205 19648510
42. Reduced risk of prostate cancer in U.S. men with AIDS. Shiels MS, Goedert JJ, Moore RD, Platz EA, Engels EA, Cancer Epidemiol Biomarkers Prev 19 11 2910 2915
43. Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS. Goedert JJ, Schairer C, McNeel TS, Hessol NA, Rabkin CS, Engels EA, Br J Cancer 2006 95 5 642 648 10.1038/sj.bjc.6603282 16868538 (Pubitemid 44325906)
44. HIV tropism and decreased risk of breast cancer. Hessol NA, Napolitano LA, Smith D, Lie Y, Levine A, Young M, Cohen M, Minkoff H, Anastos K, D'Souza G, et al. PLoS ONE 5 12 14349
45. Living longer with HIV: what does it mean for cancer risk? Grulich AE, Curr Opin HIV AIDS 2009 4 1 1 2 10.1097/COH.0b013e32831c508a 19339933
46. Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Mbulaiteye SM, Katabira ET, Wabinga H, Parkin DM, Virgo P, Ochai R, Workneh M, Coutinho A, Engels EA, Int J Cancer 2006 118 4 985 990 10.1002/ijc.21443 16106415 (Pubitemid 43157675)
47. A case-control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda. Newton R, Ziegler J, Beral V, Mbidde E, Carpenter L, Wabinga H, Mbulaiteye S, Appleby P, Reeves G, Jaffe H, Int J Cancer 2001 92 5 622 627 10.1002/1097-0215(20010601)92:5<622::AID- IJC1256>3.0.CO;2-K 11340563 (Pubitemid 32385701)
48. Antibodies against human herpesvirus 8 in black South African patients with cancer. Sitas F, Carrara H, Beral V, Newton R, Reeves G, Bull D, Jentsch U, Pacella-Norman R, Bourboulia D, Whitby D, et al. N Engl J Med 1999 340 24 1863 1871 10.1056/NEJM199906173402403 10369849 (Pubitemid 29272666)
49. Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS. Wabinga HR, Parkin DM, Wabwire-Mangen F, Mugerwa JW, Int J Cancer 1993 54 1 26 36 10.1002/ijc.2910540106 8478145 (Pubitemid 23136995)
50. Conjunctival squamous-cell carcinoma associated with HIV infection in Kampala, Uganda. Ateenyi-Agaba C, Lancet 1995 345 8951 695 696 10.1016/S0140-6736(95)90870-6 7885126
51. Non-Hodgkin lymphoma in Uganda: a case-control study. Parkin DM, Garcia-Giannoli H, Raphael M, Martin A, Katangole-Mbidde E, Wabinga H, Ziegler J, Aids 2000 14 18 2929 2936 10.1097/00002030-200012220-00015 11153674 (Pubitemid 32042757)
52. Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Wabinga HR, Parkin DM, Wabwire-Mangen F, Nambooze S, Br J Cancer 2000 82 9 1585 1592 10789729 (Pubitemid 30204367)
53. Cancer incidence in the African population of Harare, Zimbabwe: second results from the cancer registry 1993-1995. Chokunonga E, Levy LM, Bassett MT, Mauchaza BG, Thomas DB, Parkin DM, Int J Cancer 2000 85 1 54 59 10.1002/(SICI)1097-0215(20000101)85:1<54::AID-IJC10>3.0.CO;2-D 10585583
54. Cancer incidence in Blantyre, Malawi 1994-1998. Banda LT, Parkin DM, Dzamalala CP, Liomba NG, Trop Med Int Health 2001 6 4 296 304 10.1046/j.1365-3156.2001.00707.x 11348520 (Pubitemid 32385855)
55. The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda. Newton R, Ziegler J, Bourboulia D, Casabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, Wabinga H, et al. Int J Cancer 2003 103 2 226 232 10.1002/ijc.10817 12455037 (Pubitemid 35461515)
56. Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30. Pelser C, Middeldorp J, Mbulaiteye SM, Lauria C, Messina A, Viviano E, Romano N, Vitale F, Goedert JJ, Infect Agent Cancer 5 18
57. Kaposi's sarcoma in pregnant women. Rabkin CS, Chibwe G, Muyunda K, Musaba E, Nature 1995 377 6544 21 author reply 22. 7659155
58. Absence of sex-hormone receptors in Kaposi's sarcoma. Ziegler JL, Katongole-Mbidde E, Wabinga H, Dollbaum CM, Lancet 1995 345 8954 925 7707830
59. Endemic Kaposi's sarcoma in Africa and local volcanic soils. Ziegler JL, Lancet 1993 342 8883 1348 1351 10.1016/0140-6736(93)92252-O 7901641 (Pubitemid 23345186)
60. Geographic heterogeneity of prevalence of the human herpesvirus 8 in sub-Saharan Africa: clues about etiology. Pfeiffer RM, Wheeler WA, Mbisa G, Whitby D, Goedert JJ, de The G, Mbulaiteye SM, Ann Epidemiol 20 12 958 963
61. Human herpesvirus 8 load and progression of AIDS-related Kaposi sarcoma lesions. Nsubuga MM, Biggar RJ, Combs S, Marshall V, Mbisa G, Kambugu F, Mehta M, Biryahwaho B, Rabkin CS, Whitby D, et al. Cancer Lett 2008 263 2 182 188 10.1016/j.canlet.2007.12.025 18234418
62. Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe. Borok M, Fiorillo S, Gudza I, Putnam B, Ndemera B, White IE, Gwanzura L, Schooley RT, Campbell TB, Clin Infect Dis 51 3 342 349
63. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Ensoli B, Gendelman R, Markham P, Fiorelli V, Colombini S, Raffeld M, Cafaro A, Chang HK, Brady JN, Gallo RC, Nature 1994 371 6499 674 680 10.1038/371674a0 7935812 (Pubitemid 24327325)
64. Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults. Jaffe HW, De Stavola BL, Carpenter LM, Porter K, Cox DR, AIDS
65. Kaposi sarcoma and quinine: a potentially overlooked triggering factor in millions of Africans. Ruocco V, Ruocco E, Schwartz RA, Janniger CK, J Am Acad Dermatol 64 2 434 436
66. Part I: Cancer in Indigenous Africans-burden, distribution, and trends. Parkin DM, Sitas F, Chirenje M, Stein L, Abratt R, Wabinga H, Lancet Oncol 2008 9 7 683 692 10.1016/S1470-2045(08)70175-X 18598933 (Pubitemid 351878054)
67. Impact of infection with human immunodeficiency virus-1 (HIV) on the risk of cancer among children in Malawi-preliminary findings. Mutalima N, Molyneux EM, Johnston WT, Jaffe HW, Kamiza S, Borgstein E, Mkandawire N, Liomba GN, Batumba M, Carpenter LM, et al. Infect Agent Cancer 2010 5 5 10.1186/1750-9378-5-5 20152034
68. Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a case-control study. Mutalima N, Molyneux E, Jaffe H, Kamiza S, Borgstein E, Mkandawire N, Liomba G, Batumba M, Lagos D, Gratrix F, et al. PLoS ONE 2008 3 6 2505 10.1371/journal.pone. 0002505 18560562
69. Infection with human immunodeficiency virus-1 (HIV) among children with cancer in South Africa. Stefan DC, Wessels G, Poole J, Wainwright L, Stones D, Johnston WT, Newton R, Pediatr Blood Cancer 2011 56 1 77 79 10.1002/pbc.22672 21110416
70. HIV-associated lymphoma in Africa: an autopsy study in Cote d'Ivoire. Lucas SB, Diomande M, Hounnou A, Beaumel A, Giordano C, Kadio A, Peacock CS, Honde M, De Cock KM, Int J Cancer 1994 59 1 20 24 10.1002/ijc.2910590106 7927898 (Pubitemid 24310942)
71. Adult Burkitt's lymphoma in patients with and without human immunodeficiency virus infection in Kenya. Otieno MW, Remick SC, Whalen C, Int J Cancer 2001 92 5 687 691 10.1002/1097-0215(20010601)92:5<687::AID- IJC1246>3.0.CO;2-Z 11340573 (Pubitemid 32385711)
72. Cancer and HIV infection in Rwanda. Newton R, Grulich A, Beral V, Sindikubwabo B, Ngilimana PJ, Nganyira A, Parkin DM, Lancet 1995 345 8961 1378 1379 7752795
73. The spectrum of HIV-1 related cancers in South Africa. Sitas F, Pacella-Norman R, Carrara H, Patel M, Ruff P, Sur R, Jentsch U, Hale M, Rowji P, Saffer D, et al. Int J Cancer 2000 88 3 489 492 10.1002/1097-0215(20001101)88: 3<489::AID-IJC25>3.0.CO;2-Q 11054682
74. The spectrum of human immunodeficiency virus-associated cancers in a South African black population: results from a case-control study, 1995-2004. Stein L, Urban MI, O'Connell D, Yu XQ, Beral V, Newton R, Ruff P, Donde B, Hale M, Patel M, et al. Int J Cancer 2008 122 10 2260 2265 10.1002/ijc.23391 18241034 (Pubitemid 351542329)
75. Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study. Morgan D, Mahe C, Mayanja B, Whitworth JA, Bmj 2002 324 7331 193 196 10.1136/bmj.324.7331.193 11809639 (Pubitemid 34107081)
76. Mortality impact of the AIDS epidemic: evidence from community studies in less developed countries. Boerma JT, Nunn AJ, Whitworth JA, Aids 1998 12 Suppl 1 3 14 9677185
77. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? Morgan D, Mahe C, Mayanja B, Okongo JM, Lubega R, Whitworth JA, Aids 2002 16 4 597 603 10.1097/00002030-200203080-00011 11873003 (Pubitemid 34218855)
78. Accuracy of Burkitt lymphoma diagnosis in constrained pathology settings: importance to epidemiology. Ogwang MD, Zhao W, Ayers LW, Mbulaiteye SM, Arch Pathol Lab Med 135 4 445 450
79. Self-reported use of anti-malarial drugs and health facility management of malaria in Ghana. Buabeng KO, Duwiejua M, Dodoo AN, Matowe LK, Enlund H, Malar J 2007 6 85 10.1186/1475-2875-6-85 17605775 (Pubitemid 47076246)
80. Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis. Maclean KH, Dorsey FC, Cleveland JL, Kastan MB, J Clin Invest 2008 118 1 79 88 10.1172/JCI33700 18097482
81. HIV-associated immune dysfunction and viral infection: role in the pathogenesis of AIDS-related lymphoma. Epeldegui M, Vendrame E, Martinez-Maza O, Immunol Res 48 1-3 72 83
82. Tuberculosis treatment in HIV infected Ugandans with CD4 counts > 350 cells/mm reduces immune activation with no effect on HIV load or CD4 count. Mahan CS, Walusimbi M, Johnson DF, Lancioni C, Charlebois E, Baseke J, Chervenak KA, Mugerwa RD, Havlir DV, Mayanja-Kizza H, et al. PLoS ONE 5 2 9138
83. HPV-related neoplasias in HIV-infected individuals. Del Mistro A, Chieco Bianchi L, Eur J Cancer 2001 37 10 1227 1235 10.1016/S0959-8049(01)00107-1 11423255 (Pubitemid 32553768)
84. The relationship between HIV infection and cervical intraepithelial neoplasia among women attending two family planning clinics in Nairobi, Kenya. Maggwa BN, Hunter DJ, Mbugua S, Tukei P, Mati JK, Aids 1993 7 5 733 738 10.1097/00002030-199305000-00019 8318180 (Pubitemid 23204969)
85. Use of a hybrid capture assay of self-collected vaginal swabs in rural Uganda for detection of human papillomavirus. Serwadda D, Wawer MJ, Shah KV, Sewankambo NK, Daniel R, Li C, Lorincz A, Meehan MP, Wabwire-Mangen F, Gray RH, J Infect Dis 1999 180 4 1316 1319 10.1086/315026 10479163 (Pubitemid 30070219)
86. Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women. La Ruche G, You B, Mensah-Ado I, Bergeron C, Montcho C, Ramon R, Toure-Coulibaly K, Welffens-Ekra C, Dabis F, Orth G, Int J Cancer 1998 76 4 480 486 10.1002/(SICI)1097- 0215(19980518)76:4<480::AID-IJC6>3.0.CO;2-N 9590121 (Pubitemid 28227988)
87. Squamous intraepithelial lesions of the cervix, invasive cervical carcinoma, and immunosuppression induced by human immunodeficiency virus in Africa. Dyscer-CI Group. La Ruche G, Ramon R, Mensah-Ado I, Bergeron C, Diomande M, Sylla-Koko F, Ehouman A, Toure-Coulibaly K, Welffens-Ekra C, Dabis F, Cancer 1998 82 12 2401 2408 9635533 (Pubitemid 28283447)
88. HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: a case-control study. Moodley JR, Hoffman M, Carrara H, Allan BR, Cooper DD, Rosenberg L, Denny LE, Shapiro S, Williamson AL, BMC Cancer 2006 6 135 10.1186/1471-2407-6-135 16719902 (Pubitemid 43933647)
89. Human immunodeficiency virus, human papillomavirus, and cervical intraepithelial neoplasia in Nairobi prostitutes. Kreiss JK, Kiviat NB, Plummer FA, Roberts PL, Waiyaki P, Ngugi E, Holmes KK, Sex Transm Dis 1992 19 1 54 59 10.1097/00007435-199201000-00011 1313992
90. The interrelation of HIV, cervical human papillomavirus, and neoplasia among antenatal clinic attenders in Tanzania. Mayaud P, Gill DK, Weiss HA, Uledi E, Kopwe L, Todd J, ka-Gina G, Grosskurth H, Hayes RJ, Mabey DC, et al. Sex Transm Infect 2001 77 4 248 254 10.1136/sti.77.4.248 11463923 (Pubitemid 32682138)
91. Cervical dysplasia and HIV type 1 infection in African pregnant women: a cross sectional study, Kigali, Rwanda. The Pregnancy and HIV Study Group (EGE). Leroy V, Ladner J, De Clercq A, Meheus A, Nyiraziraje M, Karita E, Dabis F, Sex Transm Infect 1999 75 2 103 106 10.1136/sti.75.2.103 10448362 (Pubitemid 29236999)
92. Risk factors for cervical squamous intraepithelial lesions among HIV-1 seropositive women in Dar es Salaam, Tanzania. Kapiga SH, Msamanga GI, Spiegelman D, Mwakyoma H, Fawzi WW, Hunter DJ, Int J Gynaecol Obstet 1999 67 2 87 94 10.1016/S0020-7292(99)00125-3 10636052 (Pubitemid 29490975)
93. Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women. Anastos K, Hoover DR, Burk RD, Cajigas A, Shi Q, Singh DK, Cohen MH, Mutimura E, Sturgis C, Banzhaf WC, et al. PLoS ONE 5 10 13525
94. Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa. Firnhaber C, Van Le H, Pettifor A, Schulze D, Michelow P, Sanne IM, Lewis DA, Williamson AL, Allan B, Williams S, et al. Cancer Causes Control 21 3 433 443
95. Implementation of 'see-and-treat' cervical cancer prevention services linked to HIV care in Zambia. Mwanahamuntu MH, Sahasrabuddhe VV, Pfaendler KS, Mudenda V, Hicks ML, Vermund SH, Stringer JS, Parham GP, AIDS 2009 23 6 1 5 19279439
96. Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia. Mwanahamuntu MH, Sahasrabuddhe VV, Kapambwe S, Pfaendler KS, Chibwesha C, Mkumba G, Mudenda V, Hicks ML, Vermund SH, Stringer JS, et al. PLoS Med 8 5 1001032
97. The epidemiology of conjunctival squamous cell carcinoma in Uganda. Newton R, Ziegler J, Ateenyi-Agaba C, Bousarghin L, Casabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, et al. Br J Cancer 2002 87 3 301 308 10.1038/sj.bjc.6600451 12177799
98. Carcinoma of the conjunctiva and HIV infection in Uganda and Malawi. Waddell KM, Lewallen S, Lucas SB, Atenyi-Agaba C, Herrington CS, Liomba G, Br J Ophthalmol 1996 80 6 503 508 10.1136/bjo.80.6.503 8759259 (Pubitemid 26187086)
99. Epidermodysplasia verruciformis human papillomavirus types and carcinoma of the conjunctiva: a pilot study. Ateenyi-Agaba C, Weiderpass E, Smet A, Dong W, Dai M, Kahwa B, Wabinga H, Katongole-Mbidde E, Franceschi S, Tommasino M, Br J Cancer 2004 90 9 1777 1779 15150602 (Pubitemid 38725651)
100. HPV infection and EGFR activation/alteration in HIV-infected East African patients with conjunctival carcinoma. Yu JJ, Fu P, Pink JJ, Dawson D, Wasman J, Orem J, Mwanda WO, Zhu H, Liang X, Guo Y, et al. PLoS ONE 5 5 10477
101. Evaluating the role of human papillomaviruses in conjunctival neoplasia. Tornesello ML, Duraturo ML, Waddell KM, Biryahwaho B, Downing R, Balinandi S, Lucas SB, Buonaguro L, Buonaguro FM, Br J Cancer 2006 94 3 446 449 10.1038/sj.bjc.6602921 16404433 (Pubitemid 43237568)
102. Effect of ambient solar ultraviolet radiation on incidence of squamous-cell carcinoma of the eye. Newton R, Ferlay J, Reeves G, Beral V, Parkin DM, Lancet 1996 347 9013 1450 1451 10.1016/S0140-6736(96)91685-2 8676629 (Pubitemid 26161209)
103. Genital and cutaneous human papillomavirus (HPV) types in relation to conjunctival squamous cell neoplasia: a case-control study in Uganda. de Koning MN, Waddell K, Magyezi J, Purdie K, Proby C, Harwood C, Lucas S, Downing R, Quint WG, Newton R, Infect Agent Cancer 2008 3 12 10.1186/1750-9378-3-12 18783604
104. HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy. Lanoy E, Rosenberg PS, Fily F, Lascaux AS, Martinez V, Partisani M, Poizot-Martin I, Rouveix E, Engels EA, Costagliola D, et al. Blood 2011 118 44 49 10.1182/blood-2011-02-339275 21551234
105. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Biggar RJ, Jaffe ES, Goedert JJ, Chaturvedi A, Pfeiffer R, Engels EA, Blood 2006 108 12 3786 3791 10.1182/blood-2006-05-024109 16917006 (Pubitemid 44864560)
106. Hodgkin lymphoma in the Swiss HIV Cohort Study. Clifford GM, Rickenbach M, Lise M, Dal Maso L, Battegay M, Bohlius J, Boffi El, Amari E, Karrer U, Jundt G, Bordoni A, et al. Blood 2009 113 23 5737 5742 10.1182/blood-2009-02-204172 19336755
107. Slim disease: a new disease in Uganda and its association with HTLV-III infection. Serwadda D, Mugerwa RD, Sewankambo NK, Lwegaba A, Carswell JW, Kirya GB, Bayley AC, Downing RG, Tedder RS, Clayden SA, et al. Lancet 1985 2 8460 849 852 2864575 (Pubitemid 16242661)
108. Trends in the incidence of primary liver cancer in Central Uganda, 1960-1980 and 1991-2005. Ocama P, Nambooze S, Opio CK, Shiels MS, Wabinga HR, Kirk GD, Br J Cancer 2009 100 5 799 802 10.1038/sj.bjc.6604893 19174820
109. High prevalence of hepatitis B, C, and E markers in young sexually active adults from the Central African Republic. Pawlotsky JM, Belec L, Gresenguet G, Deforges L, Bouvier M, Duval J, Dhumeaux D, J Med Virol 1995 46 3 269 272 10.1002/jmv.1890460318 7561802
110. HIV-1 prevalence and herpes simplex virus 2, hepatitis C virus, and hepatitis B virus infections among male workers at a sugar estate in Malawi. Sutcliffe S, Taha TE, Kumwenda NI, Taylor E, Liomba GN, J Acquir Immune Defic Syndr 2002 31 1 90 97 10.1097/00126334-200209010-00012 12352155
111. High prevalence of liver fibrosis associated with HIV infection: a study in rural Rakai, Uganda. Stabinski L, Reynolds SJ, Ocama P, Laeyendecker O, Ndyanabo A, Kiggundu V, Boaz I, Gray RH, Wawer M, Thio C, et al. Antivir Ther 16 3 405 411
112. Universal HIV testing and counselling in Africa. Bunnell R, Cherutich P, Lancet 2008 371 9631 2148 2150 10.1016/S0140-6736(08)60929-0 18586156 (Pubitemid 351885023)
113. Survival of HIV-Infected Adolescents on Antiretroviral Therapy in Uganda: Findings from a Nationally Representative Cohort in Uganda. Bakanda C, Birungi J, Mwesigwa R, Nachega JB, Chan K, Palmer A, Ford N, Mills EJ, PLoS ONE 6 4 19261
114. The evolution of the population-based cancer registry. Parkin DM, Nat Rev Cancer 2006 6 8 603 612 10.1038/nrc1948 16862191 (Pubitemid 44144028)
115. The AMPATH medical record system: creating, implementing, and sustaining an electronic medical record system to support HIV/AIDS care in western Kenya. Tierney WM, Rotich JK, Hannan TJ, Siika AM, Biondich PG, Mamlin BW, Nyandiko WM, Kimaiyo S, Wools-Kaloustian K, Sidle JE, et al. Stud Health Technol Inform 2007 129 Pt 1 372 376 17911742
116. Global trends in molecular epidemiology of HIV-1 during 2000-2007. Hemelaar J, Gouws E, Ghys PD, Osmanov S, AIDS 25 5 679 689
117. The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women. Rowhani-Rahbar A, Hawes SE, Sow PS, Toure P, Feng Q, Dem A, Dembele B, Critchlow CW, N'Doye I, Kiviat NB, J Infect Dis 2007 196 6 887 894 10.1086/520883 17703420 (Pubitemid 47378939)
118. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2. Hawes SE, Critchlow CW, Sow PS, Toure P, N'Doye I, Diop A, Kuypers JM, Kasse AA, Kiviat NB, J Natl Cancer Inst 2006 98 2 100 109 10.1093/jnci/djj010 16418512 (Pubitemid 43159964)
119. PEPFAR and the fight against HIV/AIDS. Lancet 2007 369 9568 1141 10.1016/S0140-6736(07)60536-4 17416238 (Pubitemid 46527857)
120. Mark Dybul: US Global AIDS Coordinator in charge of PEPFAR. Das P, Lancet 2007 369 9568 1161 10.1016/S0140-6736(07)60549-2 17416248 (Pubitemid 46527864)
121. African Burkitt's lymphoma: could collaboration with HIV-1 and malaria programmes reduce the high mortality rate? Mbulaiteye SM, Talisuna AO, Ogwang MD, McKenzie FE, Ziegler JL, Parkin DM, Lancet 375 9726 1661 1663
122. Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study. Mermin J, Were W, Ekwaru JP, Moore D, Downing R, Behumbiize P, Lule JR, Coutinho A, Tappero J, Bunnell R, Lancet 2008 371 9614 752 759 10.1016/S0140-6736(08)60345-1 18313504 (Pubitemid 351297773)
123. Role of the US President's Emergency Plan for AIDS Relief in responding to tuberculosis and HIV coinfection. Coggin WL, Ryan CA, Holmes CB, Clin Infect Dis 50 Suppl 3 255 259
124. Cohort Profile: The international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa. Egger M, Ekouevi DK, Williams C, Lyamuya RE, Mukumbi H, Braitstein P, Hartwell T, Graber C, Chi BH, Boulle A, et al. Int J Epidemiol 2011
125. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. Bower M, Nelson M, Young AM, Thirlwell C, Newsom-Davis T, Mandalia S, Dhillon T, Holmes P, Gazzard BG, Stebbing J, J Clin Oncol 2005 23 22 5224 5228 10.1200/JCO.2005.14.597 16051964 (Pubitemid 46224033)
126. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. Rosen S, Fox MP, Gill CJ, PLoS Med 2007 4 10 298 10.1371/journal.pmed.0040298 17941716 (Pubitemid 350035458)
127. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Fox MP, Rosen S, Trop Med Int Health 15 Suppl 1 1 15
128. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, et al. J Natl Cancer Inst 2005 97 6 425 432 10.1093/jnci/dji072 15770006 (Pubitemid 40528605)
129. Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. McGowan CC, Cahn P, Gotuzzo E, Padgett D, Pape JW, Wolff M, Schechter M, Masys DR, Int J Epidemiol 2007 36 5 969 976 10.1093/ije/dym073 17846055 (Pubitemid 350018541)
130. Integrating cancer control into global health. Varmus H, Trimble EL, Sci Transl Med 3 101 101cm128
131. Breast cancer during the HIV epidemic in an African population. Amir H, Makwaya C, Mhalu F, Mbonde MP, Schwartz-Albiez R, Oncol Rep 2001 8 3 659 661 11295098 (Pubitemid 33758472)
132. Cancer in Rwanda. Newton R, Ngilimana PJ, Grulich A, Beral V, Sindikubwabo B, Nganyira A, Parkin DM, Int J Cancer 1996 66 1 75 81 10.1002/(SICI)1097-0215(19960328)66:1<75::AID-IJC14>3.0.CO;2-A 8608971 (Pubitemid 26120902)